高级检索

急性胰腺炎抗炎和免疫治疗的研究进展

Research progress of anti-inflammation therapy and immunotherapy for acute pancreatitis

  • 摘要: 目前,重度急性胰腺炎的发生率为15%~20%,死亡率20%左右,可导致患者局部或全身并发症,并产生巨大的医疗费用。急性胰腺炎的发生与炎症反应密切相关,本文对其抗炎和免疫治疗进展进行综述,旨在为急性胰腺炎患者的治疗提供参考。

     

    Abstract: At present, the incidence and mortality rate of severe acute pancreatitis is 15%-20% and about 20%, respectively, which can lead to local and systemic complications of patients and huge medical costs. The occurrence of acute pancreatitis is closely related to inflammatory response. This article reviews the progress of anti-inflammation therapy and immunotherapy of acute pancreatitis, aiming to provide reference for treatment in patients with acute pancreatitis.

     

/

返回文章
返回